Bang Ji Young, Ramesh Jayapal, Hasan Muhammad, Navaneethan Udayakumar, Holt Bronte A, Hawes Robert, Varadarajulu Shyam
Division of Gastroenterology & Hepatology, Indiana University, Indianapolis, USA.
Division of Gastroenterology & Hepatology, University of Alabama at Birmingham, Birmingham, USA.
Dig Endosc. 2016 Sep;28(6):650-6. doi: 10.1111/den.12658. Epub 2016 Apr 21.
Endoscopic ultrasound (EUS) is considered the most sensitive modality for local staging of esophageal cancer (ECA) and current guidelines recommend EUS in all patients with non-metastatic disease. Our aim was to identify a subset of patients with stenotic, non-metastatic ECA who will not benefit from staging EUS.
This multicenter study evaluated consecutive patients with newly diagnosed non-metastatic ECA referred for local staging by EUS. All patients had endoscopic evaluation of malignant strictures with 9.8/9.9-mm diagnostic gastroscope prior to EUS. Main outcome measure was to evaluate the relationship between degree of malignant stenosis and tumor staging by EUS.
Of 100 patients (median age, 65 years; male 81%), gastroscope could not be advanced past the stricture in 46, all of whom (100%) had locally advanced disease at EUS: T3N0/N+ in 39 and T4N0/N+ in seven. Echoendoscope could not traverse the stricture in any of these patients. Gastroscope could be advanced through the stricture in 54 patients in whom EUS staging was T1N0 in five, T2N0/N+ in eight and T3N0/N+ in 41; echoendoscope could not pass through the stricture in 24 of these 54 (44.4%) patients, all of whom had T3N0/N+ disease. On logistic regression analysis, inability to pass a gastroscope through the stricture was significantly associated with advanced (T3/4) tumor stage (OR = 28.7, 95% CI = 1.64-501.2; P = 0.021).
Routine EUS examination may not be required in all patients with ECA as the inability to advance a diagnostic gastroscope past a malignant stricture correlates 100% with locally advanced disease on EUS.
内镜超声(EUS)被认为是食管癌(ECA)局部分期最敏感的检查方法,目前的指南建议对所有非转移性疾病患者进行EUS检查。我们的目的是确定一组患有狭窄性、非转移性ECA且无法从分期EUS检查中获益的患者。
这项多中心研究评估了因EUS进行局部分期而转诊的新诊断非转移性ECA的连续患者。所有患者在EUS检查前均使用9.8/9.9毫米诊断胃镜对恶性狭窄进行了内镜评估。主要观察指标是评估恶性狭窄程度与EUS肿瘤分期之间的关系。
100例患者(中位年龄65岁;男性占81%)中,46例胃镜无法通过狭窄部位,所有这些患者(100%)在EUS检查时均为局部晚期疾病:39例为T3N0/N+,7例为T4N0/N+。这些患者中没有一例超声内镜能够穿过狭窄部位。54例患者胃镜能够通过狭窄部位,其中EUS分期为T1N0的有5例,T2N0/N+的有8例,T3N0/N+的有41例;在这54例患者中,24例(44.4%)超声内镜无法通过狭窄部位,所有这些患者均为T3N0/N+疾病。逻辑回归分析显示,胃镜无法通过狭窄部位与晚期(T3/4)肿瘤分期显著相关(OR = 28.7,95%CI = 1.64 - 501.2;P = 0.021)。
并非所有ECA患者都需要进行常规EUS检查,因为诊断性胃镜无法通过恶性狭窄与EUS检查显示的局部晚期疾病100%相关。